Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IRMD | Common Stock | Options Exercise | +1.27K | +7.93% | 17.3K | Jun 26, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IRMD | Restricted Stock Units | Options Exercise | $0 | -1.27K | -100% | $0.00* | 0 | Jun 26, 2021 | Common Stock | 1.27K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
F2 | On June 26, 2019, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on June 26, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |